Bioprocessing Application Notes & Case Studies

31. Characterization Of Fly-Derived Prolactin: Insights Into Glycosylation And Activity 9/26/2026

    Explore how D. mel-derived human prolactin (hPRL) compares with hPRL expressed in E. coli and HEK293 cells through detailed physico-chemical and biological characterization.

32. Characterizing Protein Stability By DSC 9/24/2026

    Discover how differential scanning calorimetry quantifies the thermodynamic forces behind protein folding and stability, providing valuable insight for protein engineering and therapeutic formulation.

33. Life Science Applications Of DSC 9/24/2026

    Learn how Differential Scanning Calorimetry directly measures macromolecular stability, unfolding, and binding interactions, providing valuable thermodynamic insights for protein engineering.

34. Perfusion Cultivations With NIST CHO Cells Using The Multifors 3 Bioreactor 9/22/2026

    Execute stable long-term perfusion with automated volume, feed, and biomass control. Maintain cell viability and high volumetric productivity with integrated bioreactor systems.

35. Metabolic Shift Monitoring Of Immune Cells During Differentiation 9/22/2026

    Real-time tracking of glucose and lactate kinetics reveals critical metabolic shifts during immune cell differentiation, enabling quantitative evaluation of cellular state changes.

36. Metabolic Rate Monitoring Of Undifferentiated iPS Cells And Expression Analysis Of Differentiation Markers 9/22/2026

    Continuous tracking of glucose and lactate kinetics provides clear quantitative indicators of stem cell pluripotency and early differentiation to optimize culture timing.

37. Visualizing The Metabolic Profile Of Immune Cells With Metabolic Inhibitors 9/22/2026

    Continuous in-line measurement tracks real-time shifts in cellular energy pathways under metabolic inhibition, delivering precise insights into immune cell function and dynamics.

38. Recombinant Erwinia Asparaginase Production 9/16/2026

    When E. coli-derived asparaginase supply failed patients with hypersensitivity, a recombinant Erwinia alternative went from project kick-off to FDA approval in approximately five years.

39. Streamline Antibody Analysis For Faster Protein Characterization 9/9/2026

    Strengthen your antibody characterization. Explore approaches for improving sizing accuracy, resolving heterogeneity, and generating reproducible data across demanding biopharmaceutical workflows.

40. Improving Accuracy In Size Measurements Of Nanomedicine 9/9/2026

    Precise particle sizing is key to formulation success. Advanced analytics overcome DLS limitations, providing reliable data that reduces risk and supports long-term product stability.